Skip to main content
. 2013 Oct 30;30(5):282–285. doi: 10.5114/pdia.2013.38356

Figure 2.

Figure 2

Comparison of IL-31 level in patients with severe AD (SCORAD > 50) and moderate AD (SCORAD 25–50)